Back to search

Article

Design of vaccine nanotechnology-based delivery systems : the effect of CpGODN TLR9 agonist-protein antigen conjugates anchored to liposomes

2020-01-01

Abstract excerpt

The efficiency of CpG oligonucleotides as Toll like receptor (TLR) 9 agonist has been well established along the last few years. Although CpGODN has shown promising results as vaccine adjuvant in preclinical and clinical studies, its in vivo stability and potential systemic toxicity have generated concern for the use of CpGODN. In an effort to increase stability, localise action and reduce dosage, different strate...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
77bf3623-bb23-55f9-8b74-a29d324e71ee
DOI
10.48730/c254-7a24
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Design of vaccine nanotechnology-based delivery systems : the effect of CpGODN TLR9 agonist-protein antigen conjugates anchored to liposomesDOI 10.48730/c254-7a24
Select a neighboring publication to make it the new centre.